Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

203629

Sigma-Aldrich

Lithium carbonate

99.997% trace metals basis

Synonym(s):

Carbolithium, Carbonic acid lithium salt

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
Li2CO3
CAS Number:
554-13-2
Molecular Weight:
73.89
Beilstein:
3999191
EC Number:
209-062-5
MDL number:
MFCD00011084
UNSPSC Code:
12352302
eCl@ss:
38020204
PubChem Substance ID:
24852186
NACRES:
NA.23

Assay

99.997% trace metals basis

form

powder

impurities

≤35.0 ppm Trace Metal Analysis

mp

618 °C (lit.)

density

2.11 g/mL at 25 °C

application(s)

battery manufacturing

SMILES string

[Li+].[Li+].[O-]C([O-])=O

InChI

1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2

InChI key

XGZVUEUWXADBQD-UHFFFAOYSA-L

Gene Information

human ... GSK3A(2931) , GSK3B(2932) , IMPA1(3612)

Looking for similar products? Visit Product Comparison Guide

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302,H319

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCD1012
MKCD9781
MKCD6538
MKBV5437V
MKBR5246V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

K E Morrison et al.
The Lancet. Neurology, 12(4), 339-345 (2013-03-05)
Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival. We aimed to assess whether lithium improves survival in
Robert L Findling et al.
Journal of child and adolescent psychopharmacology, 23(2), 80-90 (2013-03-21)
This study examined the long-term effectiveness of lithium for the treatment of pediatric bipolar disorder within the context of combination mood stabilizer therapy for refractory mania and pharmacological treatment of comorbid psychiatric conditions. Outpatients, ages 7-17 years, meeting American Psychiatric
Andrew A Nierenberg et al.
The American journal of psychiatry, 170(1), 102-110 (2013-01-05)
Lithium salts, once the mainstay of therapy for bipolar disorder, have tolerability issues at a higher dosage that often limit adherence. The authors investigated the comparative effectiveness of more tolerable dosages of lithium as part of optimized personalized treatment (OPT).
Harm-Pieter Spaans et al.
The Journal of clinical psychiatry, 74(11), e1029-e1036 (2013-12-18)
To compare the efficacy and cognitive side effects of high-dose unilateral brief pulse electroconvulsive therapy (ECT) with those of high-dose unilateral ultrabrief pulse ECT in the treatment of major depression. From April 2007 until March 2011, we conducted a prospective
Tom Bschor et al.
Journal of clinical psychopharmacology, 33(1), 38-44 (2013-01-02)
Studies of the 1970s and 1980s showed lithium monotherapy to be an effective treatment of acute unipolar major depressive disorder (MDD) and hence as a potential alternative to monoaminergic antidepressants.The objective was to conduct the first comparison of a lithium
View All Related Papers

Articles

Lithium-Ion Battery Performance: Dependence on Material Synthesis and Post‑Treatment Methods

Lithium-Ion Battery Performance: Dependence on Material Synthesis and Post‑Treatment Methods

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service